Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P. · Limited Availability · Reason: Shortage of an active ingredient
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 07/14/2023
- Package NDC
- 42858-164-01
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 888-827-0616
- Availability
- Limited Availability
- Related info
- Estimated recovery: TBD
- Update date
- 06/24/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)
- Company name
- Rhodes Pharmaceuticals L.P.
- Shortage reason
- Shortage of an active ingredient
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA215330
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Rhodes Pharmaceuticals LLC
- Product NDC
- 42858-164, 42858-161, 42858-162, 42858-163, 42858-165, 42858-166, 42858-167
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- 0002e227-1109-4ecc-a8c5-4b4f11fac3cc
- SPL set ID
- d918b40d-a461-41bc-b6c0-83dc76c28e32
- Package NDC
- 42858-161-01, 42858-162-01, 42858-163-01, 42858-164-01, 42858-165-01, 42858-166-01, 42858-167-01
- UNII
- SJT761GEGS
